Related references
Note: Only part of the references are listed.The unfolded protein response in familial amyotrophic lateral sclerosis
Lijun Wang et al.
HUMAN MOLECULAR GENETICS (2011)
The ALS8-associated mutant VAPBP56S is resistant to proteolysis in neurons
Christos Gkogkas et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
Albert C. Ludolph et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Elimination of the Native Structure and Solubility of the hVAPB MSP Domain by the Pro56Ser Mutation That Causes Amyotrophic Lateral Sclerosis
Jiahai Shi et al.
BIOCHEMISTRY (2010)
A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
Maria C. N. Marchetto et al.
CELL (2010)
The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case
A. D. Funke et al.
CLINICAL GENETICS (2010)
A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum
Elisa Fasana et al.
FASEB JOURNAL (2010)
Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases
Maria C. N. Marchetto et al.
HUMAN MOLECULAR GENETICS (2010)
Structural Requirements for VAP-B Oligomerization and Their Implication in Amyotrophic Lateral Sclerosis-associated VAP-B(P56S) Neurotoxicity
SoHui Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis
Han-Jou Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Electrostatic Interaction between Oxysterol-binding Protein and VAMP-associated Protein A Revealed by NMR and Mutagenesis Studies
Kyoko Furuita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotyp-phenotype correlations
Stephanie Millecamps et al.
JOURNAL OF MEDICAL GENETICS (2010)
Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice
Daniel Bergemalm et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord
Georgia Anagnostou et al.
NEUROBIOLOGY OF AGING (2010)
AMYOTROPHIC LATERAL SCLEROSIS MUTANT VESICLE-ASSOCIATED MEMBRANE PROTEIN-ASSOCIATED PROTEIN-B TRANSGENIC MICE DEVELOP TAR-DNA-BINDING PROTEIN-43 PATHOLOGY
E. L. Tudor et al.
NEUROSCIENCE (2010)
Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice
Chiara Pizzasegola et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives
Ana Beleza-Meireles et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Rethinking ALS: The FUS about TDP-43
Clotilde Lagier-Tourenne et al.
CELL (2009)
ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB
Hiroaki Suzuki et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Induced pluripotent stem cells from a spinal muscular atrophy patient
Allison D. Ebert et al.
NATURE (2009)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
TDP-43 A315T mutation in familial motor neuron disease
Michael A. Gitcho et al.
ANNALS OF NEUROLOGY (2008)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
The Amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors
Hiroshi Tsuda et al.
CELL (2008)
Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells
Maria C. N. Marchetto et al.
CELL STEM CELL (2008)
VAPB interacts with and modulates the activity of ATF6
Christos Gkogkas et al.
HUMAN MOLECULAR GENETICS (2008)
FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation
Derek C. Prosser et al.
JOURNAL OF CELL SCIENCE (2008)
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Edor Kabashi et al.
NATURE GENETICS (2008)
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS
J. E. Landers et al.
NEUROLOGY (2008)
VAPB - New genetic clues to the pathogenesis of ALS
Michio Hirano
NEUROLOGY (2008)
A Drosophila Model of ALS: Human ALS-Associated Mutation in VAP33A Suggests a Dominant Negative Mechanism
Anuradha Ratnaparkhi et al.
PLOS ONE (2008)
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
John T. Dimos et al.
SCIENCE (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
The VAP protein family: from cellular functions to motor neuron disease
Sima Lev et al.
TRENDS IN CELL BIOLOGY (2008)
hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction
Andrea Chai et al.
HUMAN MOLECULAR GENETICS (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates
Eva Teuling et al.
JOURNAL OF NEUROSCIENCE (2007)
A mutation in human VAP-B-MSP domain, present in ALS patients, affects the interaction with other cellular proteins
M. Mitne-Neto et al.
PROTEIN EXPRESSION AND PURIFICATION (2007)
Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8)
Kohsuke Kanekura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Proteasome inhibitor drugs on the rise
Claudio A. P. Joazeiro et al.
CANCER RESEARCH (2006)
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Piera Pasinelli et al.
NATURE REVIEWS NEUROSCIENCE (2006)
A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population
AL Nishimura et al.
HUMAN GENETICS (2005)
Structural basis of FFAT motif-mediated ER targeting
SE Kaiser et al.
STRUCTURE (2005)
A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13
AL Nishimura et al.
JOURNAL OF MEDICAL GENETICS (2004)
A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis
AL Nishimura et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner
G Pennetta et al.
NEURON (2002)
Medical progress: Amyotrophic lateral sclerosis.
LP Rowland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Mouse VAP33 is associated with the endoplasmic reticulum and microtubules
PA Skehel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
